TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/3/19 19:34 | 9/3/19 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | CA | O | EVP,Fina | P | 43 | 86.18 | 0 | 1 | 3 | 17 | D | ||||||||||||||
8/29/18 20:35 | 8/29/18 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | CA | O | EVP,Fina | M.d | 990 | 85.79 | 0 | 12 | 7 | D | |||||||||||||||
8/29/18 20:35 | 8/29/18 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | CA | O | EVP,Fina | S.d | -4,712 | 256.69 | 0 | -18 | -73 | 7 | D | ||||||||||||||
11/17/17 17:11 | 11/17/17 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | CA | O | VP,Finan | S | -936 | 142.63 | 0 | -7 | -45 | 8 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |